Quantum Biopharma Ltd. Files 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Sep 18, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Sep 18, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 6-K, foreign-private-issuer
TL;DR
Quantum Biopharma (fka FSD Pharma) filed a 6-K, confirming 20-F reporting.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on September 18, 2025, reporting for the month of September 2025. The company, incorporated in A6 and headquartered in Toronto, Ontario, is a pharmaceutical preparations company. This filing indicates they are submitting their reports under Form 20-F.
Why It Matters
This filing provides an update on Quantum Biopharma's reporting status with the SEC, confirming their adherence to regulatory requirements for foreign private issuers.
Risk Assessment
Risk Level: low — This is a routine regulatory filing and does not contain new financial or operational information that would inherently increase risk.
Key Numbers
- 001-39152 — SEC File Number (Identifies the company's filing with the SEC)
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the report
- FSD Pharma Inc. (company) — Former name of the registrant
- September 2025 (date) — Reporting period
- 20250918 (date) — Filing date
- Toronto, Ontario (location) — Company headquarters
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of September 2025.
What is the former name of Quantum Biopharma Ltd.?
The former name of Quantum Biopharma Ltd. was FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd. headquartered?
Quantum Biopharma Ltd. is headquartered at 1 Adelaide Street East, Suite 801, Toronto, Ontario M5C 2V9.
Does Quantum Biopharma Ltd. file annual reports under Form 20-F or Form 40-F?
Quantum Biopharma Ltd. indicates it files annual reports under cover of Form 20-F.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, Pharmaceutical Preparations.
Filing Stats: 152 words · 1 min read · ~1 pages · Grade level 11.9 · Accepted 2025-09-18 08:10:03
Filing Documents
- f6k_091725.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 6KB
- 0001171843-25-005957.txt ( ) — 13KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Quantum BioPharma Ltd. (Registrant) Date: September 18, 2025 /s/ Donal Carroll Donal Carroll Chief Financial Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated September 18, 2025